3-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)-3-(4-fluorophenyl)propanoic acid, 97%, 5g

ethyl 3-amino-4-nitrobenzoate, 95.0%, 500mg

Cinepazide Maleate>98.0%(HPLC)(T)1g

(R)-1,3,4,9-Tetrahydro-b-carboline-2,3-dicarboxylic acid 2-tert-butyl ester, 96.0%, 1g

Methyl 3-(tert-butyl)-1,2,4-oxadiazole-5-carboxylate, 98%, 250mg

FURO[2,3-C]PYRIDIN-3(2H)-ONE, 95.0%, 250mg

VIPADENANT, 95%, 5mg

1-(3-Bromo-5-(trifluoromethyl)pyridin-2-yl)ethanone, 98%, 100mg

3-(4-Amino-1,2,5-oxadiazol-3-yl)-4-(3-bromo-4-fluorophenyl)-1,2,4-oxadiazol-5(4H)-one, 95%, 250mg

2-Chloro-4-nitropyridine>98.0%(GC)25g

Tamis de test Ø 200 mm, 9,5 mm, 1 Pièce(s)

Solution d'hydroxyde de sodium, ROTI®Volum 1 mol/l - 1 N, ampoule, 1 pièce, emballage plastique.

1-(Methylamino)cyclopropane-1-carboxylic acid, 5g